CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: The Dose Finding Study of DAOIB Added to tDCS for AD [Phase 2]
Summary
Phase 2 dose-finding study of DAOIB added to transcranial direct current stimulation for Alzheimer's disease is underway, sponsored by Chang Gung Memorial Hospi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chang Gung Memorial Hospital | Conditions: Transcranial Direct Current Stimulation, Dementia | Phase 2 | Status: SUSPENDED